# Pioglitazone Therapy for Chronic Granulomatous Disease

> **NCT03080480** · PHASE1,PHASE2 · TERMINATED · sponsor: **Children's Hospital of Fudan University** · enrollment: 3 (actual)

## Conditions studied

- Chronic Granulomatous Disease

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT03080480
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-10-20
- **Final completion:** 2019-10-20
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The results are negtive.
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03080480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03080480, "Pioglitazone Therapy for Chronic Granulomatous Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03080480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*